摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[4-[[6-(2-azatricyclo[10.4.0.04,9]hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl)-6-oxohexanoyl]amino]butyl]-7-(diethylamino)-2-oxochromene-3-carboxamide

中文名称
——
中文别名
——
英文名称
N-[4-[[6-(2-azatricyclo[10.4.0.04,9]hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl)-6-oxohexanoyl]amino]butyl]-7-(diethylamino)-2-oxochromene-3-carboxamide
英文别名
——
N-[4-[[6-(2-azatricyclo[10.4.0.04,9]hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl)-6-oxohexanoyl]amino]butyl]-7-(diethylamino)-2-oxochromene-3-carboxamide化学式
CAS
——
化学式
C39H42N4O5
mdl
——
分子量
646.8
InChiKey
ODARIZCNIHFLFY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.1
  • 重原子数:
    48
  • 可旋转键数:
    14
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    108
  • 氢给体数:
    2
  • 氢受体数:
    6

文献信息

  • SEALANTS HAVING CONTROLLED DEGRATION
    申请人:PROLYNX LLC
    公开号:US20150352246A1
    公开(公告)日:2015-12-10
    The invention provides sealants wherein biodegradable hydrogels that do not otherwise comprise protein-reactive groups for binding to membranes or tissue are provided said groups optionally through a linker. The linker may be biodegradable and may be biodegradable by an elimination reaction. The invention also provides multilayer gels for drug delivery wherein a porous gel in contact with a tissue or organ to which the drug is to be delivered is protected by a microporous layer from the surrounding bodily fluid.
    本发明提供了密封剂,其中提供了不含有蛋白质反应性基团以结合膜或组织的可生物降解凝胶,该基团可以通过连接剂选择性引入。连接剂可以是可生物降解的,并且可以通过消除反应进行生物降解。本发明还提供了多层凝胶用于药物传递,其中与要传递药物的组织或器官接触的多孔凝胶被微孔层保护免受周围体液的影响。
  • [EN] SEALANTS HAVING CONTROLLED DEGRADATION<br/>[FR] PRODUITS D'ÉTANCHÉITÉ AYANT UNE DÉGRADATION CONTRÔLÉE
    申请人:PROLYNX LLC
    公开号:WO2014116717A1
    公开(公告)日:2014-07-31
    The invention provides sealants wherein biodegradable hydrogels that do not otherwise comprise protein-reactive groups for binding to membranes or tissue are provided said groups optionally through a linker. The linker may be biodegradable and may be biodegradable by an elimination reaction. The invention also provides multilayer gels for drug delivery wherein a porous gel in contact with a tissue or organ to which the drug is to be delivered is protected by a microporous layer from the surrounding bodily fluid.
查看更多